Ticks can become infected with more than one disease-causing microbe (called co-infection). Co-infection may be a potential problem for humans, because the Ixodes ticks that transmit Borrelia burgdorferi, the bacterium which causes Lyme disease, often carry and transmit other pathogens, as well. A single tick could make a person sick with any one—or several—diseases at the same time. Possible co-infections include Lyme borreliosis, anaplasmosis, babesiosis, and B. miyamotoi infection. In Europe and Asia, Ixodes ticks also are known to transmit tickborne encephalitis viruses, like Powassan virus. Fortunately, tickborne encephalitis viral infection has not yet been reported in the United States, although in rare instances, ticks have been found to be co-infected with B. burgdorferi and Powassan virus.
Studies have looked at co-infection rates at different points in the tick’s life cycle. In a comprehensive review of 61 different published reports, Nieto and Foley found that 2 to 5 percent of young nymphal I. scapularis ticks were reported to be co-infected with more than one microbe. Adult tick co-infection rates with B. burgdorferi varied widely between 1 to 28 percent across the reports analyzed (Vector Borne Zoonotic Dis. 9(1):93-101, 2009). Although humans are more likely to be bitten by the smaller nymphal stage ticks (CDC), co-infection rates in adult ticks may provide important information about how tickborne diseases are transmitted.
Co-infection by some or all of these other microbes may make it more difficult to diagnose Lyme disease. Being infected by more than one microbe might also affect how the immune system responds to B. burgdorferi (J Infect Dis. 186: 428, 2002). NIAID-supported studies of mice found that co-infection with human granulocytic ehrlichiosis—which is now known as anaplasmosis—results in more severe Lyme disease (Infect Immun. 69: 3359, 2001). By contrast, when mice were co-infected with B. microti and B. burgdorferi, neither microbe affected how each individual infection progressed (J Infect Dis. 192: 1634, 2005).
Another study looked at the tissues of mice infected with both B. burgdorferi and Anaplasma phagocytophilium, the bacterium that causes anaplasmosis in humans. Scientists found increased numbers of B. burgdorferi in the ears, heart, and skin of co-infected mice; however, the numbers of A. phagocytophilium remained relatively constant. The co-infected mice produced fewer antibodies for A. phagocytophilium but not for B. burgdorferi. These findings suggest that co-infection can affect the amount of microbes in the body and antibody responses (Infect Immun. 73: 3440, 2005).
In NIAID-supported clinical studies on Lyme disease, patients with persisting symptoms were examined to determine if they might have been co-infected with other tickborne infectious diseases at the time of their acute episode of Lyme disease. In one clinical study, babesioisis (B. microti), granulocytic ehrlichiosis (Anaplasma phagocytophilia), and tickborne encephalitis virus infection were evaluated. The study found that 2.5 percent of blood samples showed signs of B. microti and 8.6 percent had evidence of A. phagocytophilia. None of the patients examined were found to be positive for tickborne encephalitis viruses (Vector Borne Zoonotic Dis. 2: 255, 2002). In this study, the persistence of symptoms in the vast majority of patients with "post-Lyme syndrome" could not be attributed to co-infection with one of these microbes.
B. miyamotoi, a bacterium that is related to the bacteria that causes tick-borne relapsing fever, is known to be present in all tick species that transmit Lyme disease. In 2013, NIAID-supported investigators showed evidence of B. miyamotoi infection in the United States and studies to better understand this pathogen continue to be supported (N Engl J Med. 368(3):240-5 and 291-3, 2013). One of these preliminary studies showed patients with acute Lyme disease were more likely to be co-infected with B. miyamotoi than people who did not have Lyme disease.
How co-infection might affect disease transmission and progression is not known but could be important in diagnosing and treating Lyme and other tickborne diseases. NIAID-supported projects continue to work toward better understanding the effects of co-infection.
back to top
Last Updated December 16, 2014